-+ 0.00%
-+ 0.00%
-+ 0.00%

Neurogene names Christy Shafer chief commercial officer

PUBT·04/20/2026 11:30:19
Listen to the news
Neurogene names Christy Shafer chief commercial officer
  • Neurogene named Christy Shafer chief commercial officer to lead commercial strategy and launch readiness for NGN-401 gene therapy in Rett syndrome.
  • Shafer previously served as senior vice president and general manager, North America, at Avidity Biosciences.
  • She was formerly chief commercial officer at Marinus Pharmaceuticals, leading launch of Ztalmy for seizures linked to CDKL5 deficiency disorder.
  • Neurogene added Christine Mikail, president and CFO, to board of directors.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurogene Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202604200730BIZWIRE_USPR_____20260420_BW578021) on April 20, 2026, and is solely responsible for the information contained therein.